Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Mkilloran who wrote (10332)	7/1/1998 11:09:00 PM
From: RCMac	Read Replies (2) \| Respond to of 23519

>> Smith Barney is projecting PROFITS from MUSE of $118 mill in 2001.<< Assuming SB's estimate will prove accurate, the arithmetic might look like this: $118MM divided by 32MM shares equals about $3.69/share. Put a very modest multiple of 15 on this and you have a $55 stock in three years. More likely, a multiple of 25 for a growing healthcare stock, for a $92 stock. Or assume SB's numbers are double the right ones, you still have a $46 stock. So what's not to like about VVUS at $6? --RCM